Literature DB >> 3082399

The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat.

H Emms, G P Lewis.   

Abstract

The effects of aspirin, carboxyheptylimidazole (CHI) and creatine phosphate/creatine phosphokinase (CP/CPK) on platelet aggregation and thromboxane B2 (TxB2) formation induced by collagen have been examined in vitro. Platelets from two species, man and the rat, have been used. In man, aspirin and CHI abolished TxB2 production but only partially inhibited aggregation. CP/CPK partially inhibited aggregation and TxB2 formation. In the rat, aspirin and CHI abolished TxB2 formation but had no effect on aggregation. CP/CPK completely inhibited aggregation and partially inhibited TxB2 generation. In man, collagen-induced aggregation is largely dependent on ADP and to a lesser extent on arachidonate metabolites whereas, in the rat, ADP alone mediates aggregation induced by this agonist. The results with CP/CPK suggest that TxB2 formation is dependent either on the prior release of platelet ADP or on aggregation itself rather than being responsible for the aggregation response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082399      PMCID: PMC1916885          DOI: 10.1111/j.1476-5381.1986.tb10162.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  RELEASE OF A PLATELET-AGGREGATING SUBSTANCE (ADENOSINE DIPHOSPHATE) FROM RABBIT BLOOD PLATELETS INDUCED BY SALINE "EXTRACT" OF TENDONS.

Authors:  T HOVIG
Journal:  Thromb Diath Haemorrh       Date:  1963-07-15

2.  Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187.

Authors:  R L Kinlough-Rathbone; M A Packham; H J Reimers; J P Cazenave; J F Mustard
Journal:  J Lab Clin Med       Date:  1977-10

3.  Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.

Authors:  W Siess; P Roth; P C Weber
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

4.  Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen.

Authors:  R L Kinlough-Rathbone; J P Cazenave; M A Packham; J F Mustard
Journal:  Lab Invest       Date:  1980-01       Impact factor: 5.662

5.  Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acid.

Authors:  M Chignard; B Vargaftig
Journal:  Eur J Pharmacol       Date:  1976-07       Impact factor: 4.432

6.  Selective antagonism of prostaglandin (PG) E1, PGD2 and prostacyclin (PGI2) on human and rabbit platelets by di-4-phloretin phosphate (DPP).

Authors:  J Westwick; H Webb
Journal:  Thromb Res       Date:  1978-06       Impact factor: 3.944

7.  Bradykinin-stimulated prostaglandin E2 production by endothelial cells and its modulation by antiinflammatory compounds.

Authors:  P J Jose; D A Page; B E Wolstenholme; T J Williams; D C Dumonde
Journal:  Inflammation       Date:  1981-12       Impact factor: 4.092

8.  Radioimmunoassay of prostaglandin F-2-alpha in peripheral venous plasma from men and women.

Authors:  J F Hennam; D A Johnson; J R Newton; W P Collins
Journal:  Prostaglandins       Date:  1974-03-25

9.  Formation by phospholipase A2 of prostaglandins and thromboxane A2-like activity in the platelets of normal and essential fatty acid deficient rats. Comparison with effect on human and rabbit platelets.

Authors:  J E Vincent; F J Zijlstra
Journal:  Prostaglandins       Date:  1977

10.  The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro.

Authors:  L C Best; T K Holland; P B Jones; R G Russell
Journal:  Thromb Haemost       Date:  1980-02-29       Impact factor: 5.249

View more
  4 in total

1.  The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.

Authors:  A Sugidachi; F Asai; T Ogawa; T Inoue; H Koike
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Aggregation and/or oxygenated products of arachidonic acid are not required for collagen-induced deacylation of phosphatidylcholine in human platelets.

Authors:  L A Piché; V G Mahadevappa
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

3.  Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist.

Authors:  T F Huang; C Z Liu; S H Yang
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

4.  Antithrombotic Potential of Tormentil Extract in Animal Models.

Authors:  Natalia Marcinczyk; Dominika Jarmoc; Agnieszka Leszczynska; Agnieszka Zakrzeska; Karol Kramkowski; Jakub Strawa; Anna Gromotowicz-Poplawska; Ewa Chabielska; Michal Tomczyk
Journal:  Front Pharmacol       Date:  2017-08-15       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.